Concepedia

Andreas Wolf

AW

Statistics

Publications

35

Citations

4K

H-Index

24

Active since

1997

Affiliations

Christian-Albrechts-Universität zu Kiel(Current)

Amgen (Germany)

University of Lübeck

Amgen (United States)

University Hospital Schleswig-Holstein

Andreas Wolf is an author at Christian-Albrechts-Universität zu Kiel specializing in life sciences, immunotherapy, and cancer immunotherapy.

Publications per year

1997–2019

35

Publications

35

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

Ralf C. Bargou, Eugen Leo, Gerhard Zugmaier et al. · Science · 2008 · 1.1K citations

, , +17

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab

Matthias Klinger, Christian Brandl, Gerhard Zugmaier et al. · Blood · 2012 · 463 citations

, , +17

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot et al. · Journal of Clinical Oncology · 2016 · 421 citations

, , +17

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Klaus Brischwein, Bernd Schlereth, Benjamin Guller et al. · Molecular Immunology · 2005 · 260 citations

, , +14

Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications

Min Zhu, Benjamin Wu, Christian Brandl et al. · Clinical Pharmacokinetics · 2016 · 211 citations

, , +16

1–5 of 35